United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 22, 2026 · Filed May 26, 2026

On May 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$567.75 for US$5.39M under a trading plan, leaving 40,513 shares. Filed May 26, 2026 (Form 4).

Sold
9,500 shares
Price
US$567.75 average (US$563.27 to US$569.73)
Value
US$5.39M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 22, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 22, 2026Common StockSale47US$563.2749,966Direct
May 22, 2026Common StockSale113US$564.6649,853Direct
May 22, 2026Common StockSale382US$565.7749,471Direct
May 22, 2026Common StockSale3,210US$567.3046,261Direct
May 22, 2026Common StockSale4,407US$568.0041,854Direct
May 22, 2026Common StockSale1,181US$568.8640,673Direct
May 22, 2026Common StockSale160US$569.7340,513Direct

Source

View original at SEC

Related